Trials / Completed
CompletedNCT02982018
Clinical Evaluation of Approved and Investigational Contact Lenses Using New UV Additive
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 133 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Randomized, 8-visit dispensing study over 14 weeks to evaluate the safety and efficacy of an investigational contact lens with a new UV blocker compared to a marketed contact lens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | senofilcon A with new UV blocker | Investigational Contact Lens |
| DEVICE | senofilcon A | J\&J Marketed Contact Lens |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-02-18
- Completion
- 2017-02-18
- First posted
- 2016-12-05
- Last updated
- 2018-07-19
- Results posted
- 2018-07-19
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02982018. Inclusion in this directory is not an endorsement.